PinPoint-HR System Targeting AAVS1 for Platform Cell Line Generation & Retargeting
- The PinPoint-HR attP Placement Vector Targeting AAVS1 (# PIN410A-1)
- The All-in-one Cas9 SmartNuclease AAVS1 gRNA Vector (# CAS601A-1)
- The PinPoint Integrase Expression Plasmid (# PIN200A-1)
- The CAG PinPoint Donor Vector (# PIN510A-1)
- The CAG-GFP-T2A-Luc PinPoint Positive Control Donor Vector (# PIN600A-1)
Products
| Catalog Number | Description | Size | Price | Quantity | Add to Cart | |||
|---|---|---|---|---|---|---|---|---|
| PIN412A-KIT | PinPoint-HR System for Platform Cell Line Generation & Retargeting of AAVS1 Safe Harbor Locus (includes PIN410A-1, CAS601A-1, PIN200A-1, PIN510A-1, & PIN600A-1) | 1 Kit | $4345 |
|
||||
Overview
OverviewEfficient isogenic cell line generation and retargeting
Making cell line generation and retargeting reliable, efficient, and amenable to high-throughput production, the PinPoint-HR System for Platform Cell Line Generation and Retargeting provides all the plasmids you need for implementing the PinPoint System using CRISPR/Cas9 to place the PinPoint attP site into the AAVS1 Safe Harbor Site. Combine the advantages of AAVS1—reliable gene expression from a protected, transcriptionally active locus—with the ease and efficiency of the PinPoint Targeted Integration System.
The PinPoint-HR System Targeting AAVS1 includes:
- The PinPoint-HR attP Placement Vector Targeting AAVS1 (# PIN410A-1)
- The All-in-one Cas9 SmartNuclease AAVS1 gRNA Vector (# CAS601A-1)
- The PinPoint Integrase Expression Plasmid (# PIN200A-1)
- The CAG PinPoint Donor Vector (# PIN510A-1)
- The CAG-GFP-T2A-Luc PinPoint Positive Control Donor Vector (# PIN600A-1)
References
How It Works
How It Works
Targeted integration with the PinPoint System
Engineering cells with the PinPoint Targeted Integration System is a two-step process:
- Insertion of the PinPoint placement site (PinPoint attP) into the target genome using either the PhiC31 Integrase, which preferentially inserts into transcriptionally active sites of the genome, or the CRISPR/Cas9 System for insertion into a defined locus, such as the AAVS1 Safe Harbor Site.
- Integration of a PinPoint Vector into the pre-placed attP site. Integration is mediated by the PinPoint Integrase, which mediates a recombination event between the PinPoint attB site (located on the PinPoint Vector) and the PinPoint attP site (placed into the target genome in step 1). Because the PinPoint Integrase only recognizes your pre-placed PinPoint attP site, you get very stringent control of integration location.
A third optional step involves removal of extra vector sequences using the Cre/Lox system, leaving behind only your expression cassette and a single LoxP site.
Placing the PinPoint attP with the CRISPR/Cas9 System
When you use the PinPoint-HR attP Placement Vector to insert the PinPoint attP site, the PGK promoter on the Placement Vector combines with the promoterless puromycin marker on any of SBI’s PinPoint Donor Vectors, to enable puromycin selection only if the PinPoint Donor Vector integrates at the correct site.
Supporting Data
Supporting Data
See the PinPoint Targeted Integration System in action
Figure 1. Efficient placement of the PinPoint attP site using the PhiC31 System. Step 1 of the PinPoint Targeted Integration System—the PinPoint attP site was placed into HEK293 cells using the PinPoint-FC Placement Vector (Cat.# PIN300A-1) and the PhiC31 Integrase (Cat.# FC200PA-1). Positive cells were selected with G418 (neomycin resistance) for fourteen days and six separate lines were picked and expanded. After eleven days, the cells were fixed and stained with a solution of 50% methanol plus 1% methylene blue. The plates were washed twice with PBS and allowed to air dry. Only the plate of cells that were transfected with the PhiC31 Integrase Expression Plasmid showed a robust number of cells.
Figure 2. Targeted integration with the PinPoint Integrase and a PinPoint Donor Plasmid. Step 2 of the PinPoint Targeted Integration System—the cell lines created in Figure 1 were transfected with a Positive Control PinPoint Gene Donor Vector expressing GFP (Cat.# PIN600A-1) for precise integration. Unlike the R4 integrase used in a similar system, the PinPoint Integrase does not recognize pseudo-sites and will only integrate at its placed recognition sequence. This feature results in the increased efficiency of correctly retargeted cell lines compared to the R4 integrase system. The entire therapeutic gene expression cassette is active and fully insulated with cHS4 DNA elements.
Figure 3. The PinPoint Integrase mediated specific placement of the PinPoint Donor Vector. We used a junction PCR assay to verify that the PinPoint Donor Vector was integrated at the correct site targeted to the correct site, amplifying across the PinPoint attL site (after PinPoint mediated integration, the plasmid-borne PinPoint attP and attB sites become genomic attL and attR sites). The appearance of bands in the L1, L2, and L3 lanes only indicate the predicted, PinPoint Integrase-mediated insertion of the PIN600A-1 Donor Vector at the placed PinPoint attP site with high precision.
FAQs
Resources
Citations
Related Products
Products
| Catalog Number | Description | Size | Price | Quantity | Add to Cart | |||
|---|---|---|---|---|---|---|---|---|
| PIN412A-KIT | PinPoint-HR System for Platform Cell Line Generation & Retargeting of AAVS1 Safe Harbor Locus (includes PIN410A-1, CAS601A-1, PIN200A-1, PIN510A-1, & PIN600A-1) | 1 Kit | $4345 |
|
||||
Overview
OverviewEfficient isogenic cell line generation and retargeting
Making cell line generation and retargeting reliable, efficient, and amenable to high-throughput production, the PinPoint-HR System for Platform Cell Line Generation and Retargeting provides all the plasmids you need for implementing the PinPoint System using CRISPR/Cas9 to place the PinPoint attP site into the AAVS1 Safe Harbor Site. Combine the advantages of AAVS1—reliable gene expression from a protected, transcriptionally active locus—with the ease and efficiency of the PinPoint Targeted Integration System.
The PinPoint-HR System Targeting AAVS1 includes:
- The PinPoint-HR attP Placement Vector Targeting AAVS1 (# PIN410A-1)
- The All-in-one Cas9 SmartNuclease AAVS1 gRNA Vector (# CAS601A-1)
- The PinPoint Integrase Expression Plasmid (# PIN200A-1)
- The CAG PinPoint Donor Vector (# PIN510A-1)
- The CAG-GFP-T2A-Luc PinPoint Positive Control Donor Vector (# PIN600A-1)
References
How It Works
How It Works
Targeted integration with the PinPoint System
Engineering cells with the PinPoint Targeted Integration System is a two-step process:
- Insertion of the PinPoint placement site (PinPoint attP) into the target genome using either the PhiC31 Integrase, which preferentially inserts into transcriptionally active sites of the genome, or the CRISPR/Cas9 System for insertion into a defined locus, such as the AAVS1 Safe Harbor Site.
- Integration of a PinPoint Vector into the pre-placed attP site. Integration is mediated by the PinPoint Integrase, which mediates a recombination event between the PinPoint attB site (located on the PinPoint Vector) and the PinPoint attP site (placed into the target genome in step 1). Because the PinPoint Integrase only recognizes your pre-placed PinPoint attP site, you get very stringent control of integration location.
A third optional step involves removal of extra vector sequences using the Cre/Lox system, leaving behind only your expression cassette and a single LoxP site.
Placing the PinPoint attP with the CRISPR/Cas9 System
When you use the PinPoint-HR attP Placement Vector to insert the PinPoint attP site, the PGK promoter on the Placement Vector combines with the promoterless puromycin marker on any of SBI’s PinPoint Donor Vectors, to enable puromycin selection only if the PinPoint Donor Vector integrates at the correct site.
Supporting Data
Supporting Data
See the PinPoint Targeted Integration System in action
Figure 1. Efficient placement of the PinPoint attP site using the PhiC31 System. Step 1 of the PinPoint Targeted Integration System—the PinPoint attP site was placed into HEK293 cells using the PinPoint-FC Placement Vector (Cat.# PIN300A-1) and the PhiC31 Integrase (Cat.# FC200PA-1). Positive cells were selected with G418 (neomycin resistance) for fourteen days and six separate lines were picked and expanded. After eleven days, the cells were fixed and stained with a solution of 50% methanol plus 1% methylene blue. The plates were washed twice with PBS and allowed to air dry. Only the plate of cells that were transfected with the PhiC31 Integrase Expression Plasmid showed a robust number of cells.
Figure 2. Targeted integration with the PinPoint Integrase and a PinPoint Donor Plasmid. Step 2 of the PinPoint Targeted Integration System—the cell lines created in Figure 1 were transfected with a Positive Control PinPoint Gene Donor Vector expressing GFP (Cat.# PIN600A-1) for precise integration. Unlike the R4 integrase used in a similar system, the PinPoint Integrase does not recognize pseudo-sites and will only integrate at its placed recognition sequence. This feature results in the increased efficiency of correctly retargeted cell lines compared to the R4 integrase system. The entire therapeutic gene expression cassette is active and fully insulated with cHS4 DNA elements.
Figure 3. The PinPoint Integrase mediated specific placement of the PinPoint Donor Vector. We used a junction PCR assay to verify that the PinPoint Donor Vector was integrated at the correct site targeted to the correct site, amplifying across the PinPoint attL site (after PinPoint mediated integration, the plasmid-borne PinPoint attP and attB sites become genomic attL and attR sites). The appearance of bands in the L1, L2, and L3 lanes only indicate the predicted, PinPoint Integrase-mediated insertion of the PIN600A-1 Donor Vector at the placed PinPoint attP site with high precision.